Table 1 Associations between plasma HSP90α levels and clinical characteristics of HCC patients
From: Diagnostic value of plasma HSP90α levels for detection of hepatocellular carcinoma
Clinico-pathological characteristics | N (659) | HSP90α (ng/mL) | P | |
|---|---|---|---|---|
Age (years) | < 50 | 296 | 162.56 ± 8.22 | 0.001 |
≥50 | 363 | 129.02 ± 5.96 | ||
Gender | Male | 568 | 145.70 ± 5.45 | 0.419 |
Female | 91 | 134.02 ± 11.91 | ||
BCLC stage | A | 196 | 85.07 ± 5.03 | 0.000 |
B | 136 | 108.11 ± 6.47 | ||
C | 309 | 189.91 ± 8.33 | ||
D | 18 | 271.84 ± 44.75 | ||
AFP (ng/mL) | < 400 | 352 | 110.93 ± 5.14 | 0.000 |
≥400 | 307 | 182.10 ± 8.41 | ||
Liver Cirrhosis | Absent | 367 | 151.42 ± 7.10 | 0.099 |
Present | 292 | 134.86 ± 6.80 | ||
HBV infection | Absent | 178 | 139.84 ± 8.81 | 0.605 |
Present | 481 | 145.65 ± 6.00 | ||
Tumor size | ≥5 cm | 483 | 168.09 ± 6.21 | 0.000 |
2–4.99 cm | 146 | 78.72 ± 5.40 | ||
< 2 cm | 30 | 75.69 ± 11.37 | ||
Tumor number | Single | 363 | 124.66 ± 5.63 | 0.000 |
Multiple | 296 | 167.92 ± 8.48 | ||
PVTT | Absent | 417 | 113.58 ± 5.21 | 0.000 |
Present | 242 | 196.65 ± 9.24 | ||
EHM | Absent | 542 | 127.49 ± 5.03 | 0.000 |
Present | 117 | 220.97 ± 13.55 | ||
Child-Pugh class | A | 466 | 121.40 ± 5.23 | 0.000 |
B | 164 | 200.40 ± 11.49 | ||
C | 29 | 190.14 ± 24.27 |